Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Neurology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Lamictal Chewable Dispersible Tablets

Company: GlaxoSmithKline
Approval Status: Approved August 1998
Treatment Area: Epilepsy

General Information

Lamictal tablets are used for the treatment of Lennox-Gastaut syndrome seizures of patients with severe forms of epilepsy.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.